iLoveBenefits: Industry News Blog

The escalating cost of new cancer drugs

More than 100 of the country’s most prominent cancer doctors are calling for a mass mobilization of patients to fight the escalating cost of new cancer drugs, which are routinely topping $100,000 a year.  It is the latest move in a flurry of physician advocacy over the price of these therapies, which has included high-profile efforts to ensure costs are factored into decisions about how to treat patients. Employer groups and insurers, stung by the huge bills, have also joined the fight, as have some consumer advocates.

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment